The abstract is read at the publisher; the summary is JClub's.
Prime-LS, an excipient-free lyophilized MSC-secretome, preserves immunomodulatory mediators and vesicles and prevents disease onset in a murine colitis model.
- Why it matters: UC remains difficult to treat durably, and current therapies can have limited efficacy or adverse effects, motivating safer, scalable cell-free options.
- What they did: Prime-LS was lyophilized and reconstituted without cryoprotectants, retaining soluble immunomodulatory mediators and extracellular vesicle populations with characteristic markers and morphology; it also suppressed peripheral blood mononuclear cell proliferation in vitro.
- The result: In vivo subcutaneous dosing in murine colitis preserved mucosal integrity and normalized inflammation, supporting a stable formulation with preserved function for translational development in UC and other immune-mediated diseases.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.